Product category:
General lab equipment
News Release from: Pantec Biosolutions | Subject: Please
Edited by the Laboratorytalk Editorial
Team on 24 January 2008
Drug delivery platform is sure to Please
At the drug delivery conference, Pantec will publicly unveil its laser microporation technology, Please, a hand held drug delivery device for the painless delivery of large molecular weight drugs
Pantec Biosolutions, a private drug delivery company focused on innovative transdermal delivery of large molecular weight drugs, will present its novel Please intraepidermal drug delivery platform at the Drug Delivery Partnerships 2008 conference in San Diego, 21-23 January 2008 Please stands for painless laser epidermal system
This article was originally published on Laboratorytalk on 10 Jan 2003 at 8.00am (UK)
Related stories
Aqueous solution conductivity determined precisely
The new Model 3084 from Amber Science is a bench top, line powered, micro-processor based conductivity instrument designed to precisely determine the conductivity of aqueous solutions.
384 rack code reader
Created to meet the growing need in biotechnology and pharmaceutical R and D communities for individual identification of ever smaller quantities of fluid or dry samples
In its company presentation, Pantec will be discussing the development and production of the most efficient hand held laser microporator of its size, Please, and the company's latest preclinical data, demonstrating the drug delivery platform's use in the therapeutic areas of in vitro fertilisation (IVF), endocrinology and pain.
These achievements have enabled Pantec Biosolutions to implement its clinical strategy for IFV hormone treatment, with the ultimate objective of offering the Please platform technology, combined with drug patch product solutions, to licensing partners in a one stop shop concept.
Christof Boehler, Pantec Biosolutions CEO, said: "We are proud to be presenting our novel Please platform for the first time to our potential licensing partners.
"After just three years of development, we are now in the position to showcase the hand held device and to unveil promising preclinical data".
Commenting on the development of the device, Pantec Biosolutions CTO, Thomas Bragagna, said: "In order to achieve such a task within three years, our team developed a second to none interdisciplinary approach to create a system that is as simple as it is high-tech.
"We have designed a drug delivery device which is convenient and safe to use for both medical professionals and patients".
• Pantec Biosolutions: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
